Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients

BACKGROUND: The mainstay of treatment for advanced ovarian cancer is debulking surgery followed by chemotherapy that includes carboplatin and paclitaxel, but the prognosis is poor. This study is aimed at evaluating the efficacy and safety of cytoreductive surgery plus hyperthermic intraperitoneal ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jue, Li, Xin-bao, Ji, Zhong-he, Ma, Ru, Bai, Wen-pei, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245244/
https://www.ncbi.nlm.nih.gov/pubmed/34258265
http://dx.doi.org/10.1155/2021/5533134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245244/
https://www.ncbi.nlm.nih.gov/pubmed/34258265
http://dx.doi.org/10.1155/2021/5533134

Ejemplares similares